Evidence map›Paper›PMID 32460636›Full record

ArticleStem cells and development2020

Anti-DKK1 Enhances the Early Osteogenic Differentiation of Human Adipose-Derived Stem/Stromal Cells.

Yiyun Wang, Stefano Negri, Zhao Li, Jiajia Xu, Ching-Yun Hsu, Bruno Peault, Kristen Broderick, Aaron W James

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Yiyun WangDepartment of Pathology and Johns Hopkins University, Baltimore, Maryland, USA.
Stefano NegriDepartment of Pathology and Johns Hopkins University, Baltimore, Maryland, USA.
Zhao LiDepartment of Pathology and Johns Hopkins University, Baltimore, Maryland, USA.
Jiajia XuDepartment of Pathology and Johns Hopkins University, Baltimore, Maryland, USA.
Ching-Yun HsuDepartment of Pathology and Johns Hopkins University, Baltimore, Maryland, USA.
Bruno PeaultUCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Pittsburgh, Pennsylvania, USA.
Kristen BroderickDepartment of Plastic Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Aaron W JamesDepartment of Pathology and Johns Hopkins University, Baltimore, Maryland, USA.
Johns Hopkins University · USMRC Centre for Regenerative Medicine · GB

Funding

Direct and indirect contributions of perivascular stem cells to bone healingR01AR070773 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI JAMES, AARON W · 2017 to 2021
$1.4M
NELL-1 isoforms for the systemic treatment of osteoporosisK08AR068316 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JAMES, AARON W · 2015 to 2019
$534k
Chief Scientist Office CGA/18/33Medical Research Council G1000816NIAMS NIH HHS K08 AR068316NIAMS NIH HHS R01 AR070773
6 · The paper itself

Abstract

Adipose-derived stem/stromal cells (ASCs) have been previously used for bone repair. However, significant cell heterogeneity exists within the ASC population, which has the potential to result in unreliable bone tissue formation and/or low efficacy. Although the use of cell sorting to lower cell heterogeneity is one method to improve bone formation, this is a technically sophisticated and costly process. In this study, we tried to find a simpler and more deployable solution-blocking antiosteogenic molecule Dickkopf-1 (DKK1) to improve osteogenic differentiation. Human adipose-derived stem cells were derived from = 5 samples of human lipoaspirate. In vitro, anti-DKK1 treatment, but not anti-sclerostin (SOST), promoted ASC osteogenic differentiation, assessed by alizarin red staining and real-time polymerase chain reaction (qPCR). Increased canonical Wnt signaling was confirmed after anti-DKK1 treatment. Expression levels of

Indexed as

Cell DifferentiationOsteogenesisAdaptor Proteins, Signal TransducingAdultGene Expression RegulationHumansIntercellular Signaling Peptides and ProteinsMesenchymal Stem CellsNeutralization TestsTime FactorsWnt Signaling PathwayAdaptor Proteins, Signal TransducingDKK1 protein, humanIntercellular Signaling Peptides and ProteinsSOST protein, humanadipose-derived stem cellsDickkopf-1perivascular stem cellsclerostin

Identifiers

PMID32460636
PMCPMC7410293
OpenAlexW3028679615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.